Cesar Santa-Maria

21PUBLICATIONS

129CO-AUTHORS

Cancer diagnosisCancer geneticsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 11, 2026

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).

|Jan 28, 2026

TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2.

Nadine M Tung, Mark E Robson, Tianyu Li

|Nov 10, 2025

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.

Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria

|Oct 28, 2024

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande

|Oct 11, 2024

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.

Maria Fatteh, Jaime Wehr, Katerina Karaindrou

|Jun 03, 2024

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande

Pageof 4

Frequent Collaborators

Antonio C Wolff

Vered Stearns

Payal D Shah

Lisa A Carey

Susan M Domchek

Adam Brufsky

Hanwen Wang

Judy Garber

Theinmozhi Arulraj

Eric Winer

Frequent Collaborators

Antonio C Wolff

Vered Stearns

Payal D Shah

Lisa A Carey